Evidence map›Paper›PMID 41766648›Full record

ArticleBriefings in bioinformatics2026

Transformer-based multidimensional feature fusion for accurate prediction of lipid nanoparticles transfection efficiency.

Daohong Gong, Xiaowei Xie, Jianxin Tang, Shiliang Li, Honglin Li

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daohong GongSchool of Information Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Pudong New Area, Shanghai 201210, China.ORCID 0009-0002-5799-5494
Xiaowei XieInnovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, 3663 North Zhongshan Road, Putuo District, Shanghai 200062, China.
Jianxin TangInnovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, 3663 North Zhongshan Road, Putuo District, Shanghai 200062, China.
Shiliang LiInnovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, 3663 North Zhongshan Road, Putuo District, Shanghai 200062, China.
Honglin LiLingang Laboratory, 2380 Hechuan Road, Minhang District, Shanghai 200031, China.

Funding

National Key R&D Program of China 2022YFC3400501National Key R&D Program of China 2022YFC3400504National Natural Science Foundation of China 82425104Shanghai Rising-Star Program 23QA1402800
6 · The paper itself

Abstract

RNA-based technologies have demonstrated significant potential for diverse applications, ranging from vaccination to gene editing. However, their widespread adoption is limited by the critical challenge of efficient delivery. Lipid nanoparticles (LNPs) have emerged as a widely utilized RNA delivery system, yet their formulation design and optimization primarily rely on empirical trial-and-error, which is labor-intensive, time-consuming, and cost-prohibitive, thus hindering the rapid development of RNA therapeutics. To facilitate the early-stage design and optimization of LNPs for enhanced delivery efficiency, in this study, we construct LNPs-TE, a benchmark dataset comprising over 10 000 experimentally measured transfection efficiency (TE) values, and introduce LNPs integrated feature fusion Transformer (LIFT), a deep learning framework for LNPs TE prediction. Comprehensive experiments demonstrate that LIFT effectively integrates multidimensional molecular representations of ionizable lipids, the key component in LNPs formulation, achieving superior predictive performance, with an average Pearson correlation coefficient of 0.845 for regression and an area under the receiver operating characteristic curve (AUC-ROC) of 0.818 for multi-class classification across multiple datasets. Through scaffold-based splitting and activity cliff tasks, we further validated the exceptional generalization ability and robustness of LIFT, which achieved over a 10% improvement in the coefficient of determination (R2) compared with state-of-the-art baseline models, highlighting its potential as a practical and stable approach for the virtual screening of efficient LNPs formulation. The relevant data, model and code are made publicly available at https://github.com/U12458/LIFT.

Indexed as

Deep LearningLipidsNanoparticlesTransfectionHumansLiposomesLipid NanoparticlesLipidsLiposomesdeep learningionizable lipidslipid nanoparticlesmultidimensional feature fusionnucleic acid delivery

Identifiers

PMID41766648
PMCPMC12951077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.